Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Updated: RPS could scrap two senior roles in executive team restructure

The Royal Pharmaceutical Society (RPS) could potentially make two senior roles within its executive board redundant as part of a strategy to strengthen the organisation’s “viability”, it has confirmed.

The RPS is “working on a proposal” that could see a restructure at executive level, with “two roles... at potential risk of redundancy”,  it said in a statement published this afternoon (March 3).

It could not confirm the two roles “that are at risk”, it told C+D.

The plans are only at proposal stage and “no final decisions or outcomes” have been reached yet, the RPS said.

It could not “go into the specifics of the process...due to its confidential nature” but “a fair, reasonable and confidential consultation process” will be adhered to, it said.

The proposal follows the launch of the RPS Strategy last year, which set out to “further strengthen the viability and sustainability of the organisation”, the RPS added.

 

“I deeply regret seeing so much speculation”

 

In an update published on March 4, RPS president Professor Claire Anderson said: “I deeply regret seeing so much speculation in the public domain about a proposed change to the executive team when no decision has yet been made and feel for those involved.”

The proposal “is not about cost savings” but it is an organisational decision on operational matters, she added.

The RPS is “completely committed” to maintaining its work on education, including post-registration curricula, assessment and credentialing, workforce planning, leadership development and mentoring, Professor Anderson said.

“Should the proposal go ahead, there would still be a leader on the executive with responsibility for delivering on our education strategy,” she clarified.

To “protect the confidentiality of the process” and “to be fair to the individuals involved”, an update will only be issued once a decision has been agreed, Professor Anderson concluded.

 

This story was updated on March 4 to include Professor Anderson's comments

 
 

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD135952

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel